Viking Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

SAN DIEGO, April 6, 2022 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its chief executive officer, Brian Lian,…

Click here to view original post